EIB Blog featuring APEIRON („Three Ways to Treat Cancer”)

The European Investment Bank blog is featuring APEIRON Biologics AG in following article: http://www.eib.org/stories/new-cancer-treatments

June 25, 2018
View the Post

APEIRON Biologics AG to present clinical data at the forthcoming annual meeting of the American Society of Clinical Oncology (ASCO).

APEIRON Biologics AG today announced it would present data on two of its key programs in three poster presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, being held on June 1-5, 2018, in Chicago, IL. Presseaussendung Press Release

May 30, 2018
View the Post

APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance With Sanofi

APEIRON Biologics AG and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that the companies received the first milestone payment from Sanofi under a 3-party alliance signed in August 2015. Press release Presseaussendung

January 8, 2018
View the Post